BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19637319)

  • 21. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
    Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.
    Li J; Wang F; Protopopov A; Malyukova A; Kashuba V; Minna JD; Lerman MI; Klein G; Zabarovsky E
    Oncogene; 2004 Aug; 23(35):5941-9. PubMed ID: 15208682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
    Gharanei S; Brini AT; Vaiyapuri S; Alholle A; Dallol A; Arrigoni E; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
    Epigenetics; 2013 Sep; 8(9):893-8. PubMed ID: 23887284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
    Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
    Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
    Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
    Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of RASSF1A hypermethylation in prostate cancer].
    Wang YC; Yu ZH; Chen LB
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):822-5. PubMed ID: 17929562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procholecystokinin as marker of human Ewing sarcomas.
    Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF
    Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Avramouli A; Tsochas S; Mandala E; Katodritou E; Ioannou M; Ritis K; Speletas M
    Leuk Res; 2009 Aug; 33(8):1130-2. PubMed ID: 19193434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
    Yang Q; Kiernan CM; Tian Y; Salwen HR; Chlenski A; Brumback BA; London WB; Cohn SL
    Clin Cancer Res; 2007 Jun; 13(11):3191-7. PubMed ID: 17545522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RASSF1A tumor suppressor.
    Donninger H; Vos MD; Clark GJ
    J Cell Sci; 2007 Sep; 120(Pt 18):3163-72. PubMed ID: 17878233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.
    Göbel G; Auer D; Gaugg I; Schneitter A; Lesche R; Müller-Holzner E; Marth C; Daxenbichler G
    Breast Cancer Res Treat; 2011 Nov; 130(1):109-17. PubMed ID: 21221769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma.
    Alholle A; Brini AT; Gharanei S; Vaiyapuri S; Arrigoni E; Dallol A; Gentle D; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
    Epigenetics; 2013 Nov; 8(11):1198-204. PubMed ID: 24005033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma.
    Nestheide S; Bridge JA; Barnes M; Frayer R; Sumegi J
    Pediatr Blood Cancer; 2013 Sep; 60(9):1437-46. PubMed ID: 23508900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.
    Ferreira BI; Alonso J; Carrillo J; Acquadro F; Largo C; Suela J; Teixeira MR; Cerveira N; Molares A; Goméz-López G; Pestaña A; Sastre A; Garcia-Miguel P; Cigudosa JC
    Oncogene; 2008 Mar; 27(14):2084-90. PubMed ID: 17952124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
    Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
    Endocr Relat Cancer; 2007 Mar; 14(1):125-34. PubMed ID: 17395981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of the Rassf1a gene and its aberrant DNA methylation in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
    Shimizu K; Itsuzaki Y; Fujii H; Honoki K; Tsujiuchi T
    Mol Carcinog; 2008 Feb; 47(2):80-7. PubMed ID: 17849420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.